September 5th, 2021: “EURETINA-Brief”© Issue No. 242 by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the September 5th, 2021 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is designed to accommodate the very busy schedules of all our members by providing them with a short overview of some new developments and announcements in our field over recent weeks. The current issue highlights a…
EURETINA’s
DIGITAL
NEWSLETTER
1
Featured Articles
September 5th, 2021
Latest News
Regeneron announces that its high-dose aflibercept (8mg) has met primary end-point in Phase II data for wet AMD.
In their press release, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced that an ongoing Phase…
A systematic review and meta-analysis on individual participant data, within 5 RCTs, on the treatment of ocriplasmin for vitreomacular adhesion resolution.
Researchers from King’s College London, UK have published a systematic review and meta-analysis on individual…
Survey data on E-cigarette use from >1 million participants shows concerns about visual impairment.
A recent research presentation from a clinical ophthalmology group in UCLA has reported that “e-cigarette”…